TRAW - Traws Pharma, Inc.
1.6
-0.080 -5.000%
Share volume: 33,124
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$1.68
-0.08
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-13-2025 | |
| Total revenue | 56.000 K | 57.000 K | 57.000 K | 57.000 K | 2.733 M | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 56.000 K | 57.000 K | 57.000 K | 57.000 K | 2.733 M | 0.000 | |
| 1.79% | 0.00% | 0.00% | 4,694.74% | -100.00% | |||
| Operating expenses | 5.268 M | 123.405 M | 8.593 M | 5.260 M | 3.982 M | 4.055 M | |
| Selling general and admin | 3.356 M | 1.977 M | 3.480 M | 2.754 M | 1.691 M | 1.744 M | |
| Research and development | 1.912 M | 121.428 M | 5.113 M | 2.506 M | 2.291 M | 2.311 M | |
| Total expenses | 5.268 M | 123.405 M | 8.593 M | 5.260 M | 3.982 M | 4.055 M | |
| 2,242.54% | -93.04% | -38.79% | -24.30% | 1.83% | |||
| Operating income | -5.212 M | -123.348 M | -8.536 M | -5.203 M | -1.249 M | -4.055 M | |
| Ebit | -4.983 M | -123.143 M | -8.475 M | 21.310 M | -1.103 M | -4.058 M | |
| Pretax income | -4.983 M | -123.143 M | -8.475 M | 21.310 M | -1.103 M | -4.058 M | |
| 2,371.26% | -93.12% | -351.45% | -105.18% | 267.91% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.983 M | -123.143 M | -8.475 M | 21.490 M | -915.000 K | -3.962 M | |
| -2,371.26% | 93.12% | 353.57% | -104.26% | -333.01% |